246 related articles for article (PubMed ID: 2198315)
1. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.
Grosset JH; Ji BH; Guelpa-Lauras CC; Perani EG; N'Deli LN
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):281-95. PubMed ID: 2198315
[TBL] [Abstract][Full Text] [Related]
2. Ofloxacin for the treatment of leprosy.
Ji B; Grosset J
Acta Leprol; 1991; 7(4):321-6. PubMed ID: 1950440
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of pefloxacin in the treatment of lepromatous leprosy.
N'Deli L; Guelpa-Lauras CC; Perani EG; Grosset JH
Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):12-8. PubMed ID: 2181041
[TBL] [Abstract][Full Text] [Related]
4. A clinical trial of pefloxacin and ofloxacin in lepromatous leprosy.
Fajardo TT; Villahermosa LG; Cruz EC; Cellona RV; Balagon MV; Abalos RM; Gelber RH
Lepr Rev; 2004 Dec; 75(4):389-97. PubMed ID: 15685736
[TBL] [Abstract][Full Text] [Related]
5. Activity of two doses of rifampin against Mycobacterium leprae.
Husser JA; Traore I; Daumerie D
Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):359-64. PubMed ID: 7963907
[TBL] [Abstract][Full Text] [Related]
6. Minocycline in lepromatous leprosy.
Fajardo TT; Villahermosa LG; dela Cruz EC; Abalos RM; Franzblau SG; Walsh GP
Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):8-17. PubMed ID: 7730723
[TBL] [Abstract][Full Text] [Related]
7. An experimental study to evaluate the bactericidal activity of ofloxacin against an established Mycobacterium leprae infection.
Banerjee DK; McDermott-Lancaster RD
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):410-5. PubMed ID: 1474279
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients.
Ji B; Jamet P; Perani EG; Sow S; Lienhardt C; Petinon C; Grosset JH
Antimicrob Agents Chemother; 1996 Sep; 40(9):2137-41. PubMed ID: 8878595
[TBL] [Abstract][Full Text] [Related]
9. Superiority of the neonatally thymectomized Lewis rat (NTLR) to monitor a clinical trial in lepromatous leprosy of the two regimens of rifampin and dapsone.
Gelber RH; Humphres RC; Fieldsteel AH
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):273-83. PubMed ID: 3522770
[TBL] [Abstract][Full Text] [Related]
10. OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil.
Cunha Mda G; Virmond M; Schettini AP; Cruz RC; Ura S; Ghuidella C; Viana Fdos R; Avelleira JC; Campos AA; Filho B
Lepr Rev; 2012 Sep; 83(3):261-8. PubMed ID: 23356027
[TBL] [Abstract][Full Text] [Related]
11. Treatment of bacilliferous BL/LL cases with combined chemotherapy and immunotherapy.
Katoch K; Katoch VM; Natrajan M; Bhatia AS; Sreevatsa ; Gupta UD; Sharma VD; Shivannavar CT; Patil MA; Bharadwaj VP
Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):202-12. PubMed ID: 7602215
[TBL] [Abstract][Full Text] [Related]
12. Ofloxacin containing combined drug regimens in the treatment of multibacillary leprosy.
Sampoonachot P; Bundit C; Kuhacharoen N; Peerapakorn S; Kampirapap K; Poomlek A; Bampenyu S; Tiasiri S; Rungruang S; Surasondhi S; Supanwanit S; Wiriyawipart S
Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):803-10. PubMed ID: 9656405
[TBL] [Abstract][Full Text] [Related]
13. Results of a modified WHO regimen in highly bacilliferous BL/LL patients.
Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa ; Sharma VD; Shivannavar CT; Katoch VM
Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):451-7. PubMed ID: 2664042
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of minocycline in single dose and at 100 mg twice daily for lepromatous leprosy.
Gelber RH; Murray LP; Siu P; Tsang M; Rea TH
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):568-73. PubMed ID: 7868955
[TBL] [Abstract][Full Text] [Related]
16. Short-term trial of clofazimine in previously untreated lepromatous leprosy.
Jamet P; Traore I; Husser JA; Ji B
Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):542-8. PubMed ID: 1299709
[TBL] [Abstract][Full Text] [Related]
17. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
18. Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice.
Ji B; Perani EG; Petinon C; Grosset JH
Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):556-61. PubMed ID: 1338596
[TBL] [Abstract][Full Text] [Related]
19. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
Mane I; Cartel JL; Grosset JH
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
[TBL] [Abstract][Full Text] [Related]
20. Bactericidal activity of a single-dose combination of ofloxacin plus minocycline, with or without rifampin, against Mycobacterium leprae in mice and in lepromatous patients.
Ji B; Sow S; Perani E; Lienhardt C; Diderot V; Grosset J
Antimicrob Agents Chemother; 1998 May; 42(5):1115-20. PubMed ID: 9593137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]